Merck Obtains Access To SurModics’ Ophthalmic Drug Delivery System In Potential $300 Million Deal
This article was originally published in The Pink Sheet Daily
Executive Summary
I-vation system is currently being studied in combination with triamcinolone acetonide for treatment of diabetic macular edema.